0000899243-22-037426.txt : 20221202 0000899243-22-037426.hdr.sgml : 20221202 20221202162018 ACCESSION NUMBER: 0000899243-22-037426 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20221201 FILED AS OF DATE: 20221202 DATE AS OF CHANGE: 20221202 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Kirpekar Sahil CENTRAL INDEX KEY: 0001951712 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40493 FILM NUMBER: 221442210 MAIL ADDRESS: STREET 1: C/O ATAI LIFE SCIENCES N.V. STREET 2: WALLSTRASSE 16 CITY: BERLIN STATE: 2M ZIP: 10179 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ATAI Life Sciences N.V. CENTRAL INDEX KEY: 0001840904 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: P7 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: WALLSTRASSE 16 CITY: BERLIN STATE: 2M ZIP: 10179 BUSINESS PHONE: (617)-699-5876 MAIL ADDRESS: STREET 1: 524 BROADWAY CITY: NEW YORK STATE: NY ZIP: 10013 FORMER COMPANY: FORMER CONFORMED NAME: ATAI Life Sciences B.V. DATE OF NAME CHANGE: 20210115 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2022-12-01 0 0001840904 ATAI Life Sciences N.V. ATAI 0001951712 Kirpekar Sahil WALLSTRASSE 16 BERLIN 2M 10179 GERMANY 0 1 0 0 Chief Business Officer Stock Option 3.34 2022-12-01 4 A 0 750000 0.00 A 2032-12-01 Common Shares 750000 750000 D The stock option shall vest as to 25% of the underlying shares on November 29, 2023, and in 36 substantially equal monthly installments thereafter. /s/ Ryan Barrett, Attorney-in-fact 2022-12-02